Lumanity today announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life.
Our host Peg Crowley-Nowick and guest Christina Tankersley, PharmD, currently Sr. Director, Field Medical Team, Vaccines at Sanofi Pasteur discuss building, training, and maturing a diverse, multidisciplinary MSL team.
Lumanity acquires Innovation Edge, creating an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances.
Are you challenged by siloed structures within your Medical Affairs organization? Our latest blog, by Julie Cahill, MD, V.P., Consulting and Medical Director Services, captures the essence and importance of cross-functional integration within Medical Affairs organizations.
Lumanity brings together a diverse collection of expert perspectives to uncover innovative yet pragmatic approaches to address the diverse and complex set of challenges associated with bringing medical advances to patients.
Our host Peg Crowley-Nowick and guest Tamas Suto, Head of Global MA Oncology at Merck KGaA, Darmstadt, Germany, discuss how leading Medical Affairs (MA) organizations have begun to strategically redefine their team’s requisite executional capabilities to enhance and tailor frontline engagement initiatives.
Partnering with an Alliance and aligning your medical strategy can be a daunting task. Zipher’s own Julie Cahill, MD outlines a unique approach for developing a concise medical strategy that drives impact and demonstrates value.
Arsenal Capital Partners, a private equity firm specializing in building healthcare businesses, today announced the acquisition of Zipher Medical Affairs, a leading provider of expert medical affairs strategic consulting services in the United States.
A well-planned and comprehensive data generation program will provide you with the tools you need to be successful in preparing for launch and beyond.
Insights provide the ability to gain a clear, deep, and sometimes unexpected understanding of a complicated problem or situation. In the pharmaceutical arena, insights are external trends that are actionable and have the potential to alter medical strategy